Sustainability in Drug Delivery165

Issue No #165 Sep/Oct 2024 September 20th, 2024

Issue 165 - SepOct 2024

Inside the magazine

PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY

Philipp Ludihuser

PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY

Philipp Ludihuser and Arne Kloke highlight how SCHOTT Pharma’s collaboration with customers and partners in the pharmaceutical industry reduces the carbon emissions from the production of vials, cartridges, ampoules and syringes, as well as introducing circular solutions to increase resource efficiency.

Interview with Bespak’s Louise Righton & Benedicta Bakpa

Interview with Bespak’s Louise Righton & Benedicta Bakpa

An increasing global incidence of respiratory diseases, such as asthma and COPD, is driving demand for therapies. Simultaneously, greenhouse gas emissions continue to rise, so the pharma industry must consider how to produce much-needed nasally delivered and orally inhaled medicines whilst minimising environmental impact. Louise Righton and Benedicta Bakpa discuss the many different aspects involved in driving sustainability in inhaled drug delivery – and the next steps.

PRIORITISING SUSTAINABILITY IN PHARMA

PRIORITISING SUSTAINABILITY IN PHARMA

Jessica Buday discusses how, in partnership with West Pharmaceutical Services, Corning’s Viridian glass vials are able to simultaneously improve the sustainability and efficiency of pharmaceutical fill-finish lines compared with traditional ISO glass vials, due to their reduced glass volume and proprietary external polymeric coating.

OPPORTUNITY THROUGH INNOVATION – ENVIRONMENTAL AND SOCIAL SUSTAINABILITY IN INJECTION DEVICES

Credence MedSystems

OPPORTUNITY THROUGH INNOVATION – ENVIRONMENTAL AND SOCIAL SUSTAINABILITY IN INJECTION DEVICES

John Merhige and Dan Thayer discuss how the successful implementation of ESG principles in the pharmaceutical sector requires innovation that allows sustainability to be seen as an opportunity rather than a burden. Furthermore, the authors present the case that improving on the social aspect of ESG is just as important as improving on the environmental side.

INTERVIEW with GLENN SVEDBERG

INTERVIEW with GLENN SVEDBERG

Glenn Svedberg engages in a wide-ranging discussion around the role and importance of sustainability in the drug delivery industry, and how Nolato Group has approached implementing this critical aspect of the modern industry landscape. Mr Svedberg considers how sustainability factors play into the relationship between CDMOs like Nolato and pharma companies, the importance of materials and how to drive forward sustainability goals within pharma and drug delivery.

CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY

Baumann Medical

CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY

David Pircher provides insights from a sustainability journey, showcasing what suppliers can contribute and how innovation and partnership support a common vision. The article outlines where the industry stands and why sustainability is a top priority, with concrete examples.

FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK

FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK

Herman Rusch and Steven van Voorst discuss the steps that IGS GeboJagema has taken to provide its ESG efforts with a robust structure to build on and how doing so has made those efforts more effective and provided the company with clear, meaningful and measurable targets to work towards.

CONFERENCE SHOWCASE

DIVE INTO THE HEART OF PHARMA ”CELEBRATING 35 YEARS OF CPHI”

Join colleagues from across the industry at CPHI Milan 2024, the premier global event for pharmaceutical professionals, from October 8–10, 2024, at Fiera Milano in Milan, Italy.

SUSTAINABLE DESIGN FOR HEALTHCARE DEVICES: PATHWAYS TOWARDS NET ZERO

SUSTAINABLE DESIGN FOR HEALTHCARE DEVICES: PATHWAYS TOWARDS NET ZERO

Will Davies and Holly Milston consider sustainable pathways towards circularity in the medical device industry.

Top